Functional profile of almotriptan in animal models predictive of antimigraine activity

Author： Gras J.   Bou J.   Llenas J.   Fernandez A.G.   Palacios J.M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.410, Iss.1, 2000-12, pp. : 43-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential

By Saxena P.R.   De Vries P.   Heiligers J.P.C.   VanDenBrink A.M.   Bax W.A.   Barf T.   Wikstrom H.  

European Journal of Pharmacology, Vol. 312, Iss. 1, 1996-09 ,pp. : 53-62

Elsevier

Access to resources Recommend Favorite

BMS-181885, a 5-HT 1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential

By Saxena P.R.   De Vries P.   Heiligers J.P.C.   Bax W.A.   MaassenVanDenBrink A.   Yocca F.D.  

European Journal of Pharmacology, Vol. 351, Iss. 3, 1998-06 ,pp. : 329-339

Elsevier

Access to resources Recommend Favorite

Current Animal Models are not Predictive for Clinical Asthma

By Coleman R.A.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 87-89

Academic Press

Access to resources Recommend Favorite

Almotriptan

By Holm K.J.   Spencer C.M.  

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 159-164

Adis International

Access to resources Recommend Favorite

Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine

By Gras J.   Cardelus I.   Llenas J.   Palacios J.M.  

European Journal of Pharmacology, Vol. 410, Iss. 1, 2000-12 ,pp. : 53-59

Elsevier

Access to resources Recommend Favorite